Outcomes after stroke thrombectomy were no better with tissue plasminogen activator (tPA) withheld in the MR CLEAN-NO IV trial, suggesting that the practice of giving thrombolytics still holds in stroke.
Select stroke patients who present late to the hospital — beyond 6 hours and up to 24 hours after stroke onset — still stand to benefit from endovascular thrombectomy, confirms the AURORA meta-analysis of six randomized trials presented at the ISC 2021 Meeting.
Getting patients with suspected large-vessel occlusion (LVO) stroke to undergo immediate angiography instead of the standard CT scan speeds up time stroke treatment and improves 90-day functional outcomes, according to the ANGIOCAT study presented at the ISC 2021 Meeting.
Patients hospitalized with COVID-19 are more likely to die or have critical illness if they also have a stroke during hospitalization, according to a large dataset from the COVID-19 CVD Registry launched by AHA.
Switching from alteplase to tenecteplase led to reductions in interfacility transfer times, thus enabling earlier endovascular thrombectomy (EVT) in patients who have had a stroke, according to data presented at ISC 2021.
Icosapent ethyl may reduce the risk of ischaemic stroke in statin-treated patients who have or are at risk of atherosclerosis, according to post hoc findings of the REDUCE-IT* trial presented at ISC 2021.